| Filed On | Filing |
|---|---|
| 14 Aug 2026 | SCHEDULE 13G |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G |
| 12 Aug 2026 | 10-Q |
| 12 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 04 Aug 2026 | SCHEDULE 13G/A |
| 30 Jul 2026 | SCHEDULE 13G |
| 29 Jul 2026 |
Form 4: Quartel Adrian W, Chief Medical Officer
Granted 13,000 Restricted Stock Units |
| 29 Jul 2026 |
Form 3: Quartel Adrian W, Chief Medical Officer
No securities owned |
| 27 Jul 2026 | SCHEDULE 13G |
| 27 Jul 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 09 Jul 2026 |
Form 4: Szwarcberg Javier B., Director
Received 266 shares as a grant or award ($1.21K) |
| 26 May 2026 |
Form 4: Simpson Camilla V, Director
Granted 1,700 Stock Option (Right to Buy) |
| 26 May 2026 |
Form 4: Grey Michael G, Director
Granted 1,700 Stock Option (Right to Buy) |
| 26 May 2026 |
Form 4: Barretto-Ko Percival, Director
Granted 1,700 Stock Option (Right to Buy) |
| 26 May 2026 |
Form 4: Walbert Keli, Director
Granted 1,700 Stock Option (Right to Buy) |
| 26 May 2026 |
Form 4: Spiegelman Daniel K, Director
Granted 1,700 Stock Option (Right to Buy) |
| 26 May 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 15 May 2026 | SCHEDULE 13G/A |
Loading...
